Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study - Wikidata - wikimedia - TriplyDB

Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study

Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study

http://www.wikidata.org/entity/Q28730283

about

Spinal muscular atrophy: from gene discovery to clinical trials Spinal muscular atrophy: development and implementation of potential treatments A comparison of three electrophysiological methods for the assessment of disease status in a mild spinal muscular atrophy mouse model Evaluation of SMN protein, transcript, and copy number in the biomarkers for spinal muscular atrophy (BforSMA) clinical study Assays for the identification and prioritization of drug candidates for spinal muscular atrophy Evaluation of peripheral blood mononuclear cell processing and analysis for Survival Motor Neuron protein.SMA-MAP: a plasma protein panel for spinal muscular atrophy The Genetics of Spinal Muscular Atrophy: Progress and Challenges.Normalization of Patient-Identified Plasma Biomarkers in SMNΔ7 Mice following Postnatal SMN Restoration.The neuromuscular impact of symptomatic SMN restoration in a mouse model of spinal muscular atrophy.Baseline results of the NeuroNEXT spinal muscular atrophy infant biomarker study.Clinical and molecular cross-sectional study of a cohort of adult type III spinal muscular atrophy patients: clues from a biomarker study Spinal muscular atrophy: an update on therapeutic progress SMA valiant trial: a prospective, double-blind, placebo-controlled trial of valproic acid in ambulatory adults with spinal muscular atrophy Urinary proteomics and metabolomics in the diagnosis of pediatric disorders.Developing therapies for spinal muscular atrophy.Label-free proteomics identifies Calreticulin and GRP75/Mortalin as peripherally accessible protein biomarkers for spinal muscular atrophy.Advances in understanding the role of disease-associated proteins in spinal muscular atrophy.Spectrum of neuropathophysiology in spinal muscular atrophy type I Evaluation of potential effects of Plastin 3 overexpression and low-dose SMN-antisense oligonucleotides on putative biomarkers in spinal muscular atrophy mice

P2860

Q26824894-FDD7C187-6AFB-4B87-A867-3A5A98507EA2 Q26861377-4C184CEF-B38F-4448-BA70-12123346BC4A Q28544408-9302D627-DAE5-4871-9D70-9755F894B241 Q28730280-39B05770-E6BE-45E2-BE3B-6A5B6800091E Q34082155-75B734FE-5336-4B3F-8809-C05AD3963F6D Q34505876-F479BB15-3D2A-46D8-AF4B-F2094B5E0AEF Q34658131-DBECE7D5-DAAA-4E0C-B30E-62AF3389AEF0 Q35501975-61486F3F-920A-45F6-A4A0-5C68A53C0B84 Q36209787-4C97799D-7142-44DC-9416-5CA2FD6637E6 Q36494820-693B9967-5257-44F7-A836-776DE8182EA5 Q36565221-812D1431-A66F-45F3-B9CE-C8D419524290 Q36856405-9019D024-0B74-4CAF-AC93-0E8AD5461539 Q37302832-D26EFA2C-8E50-4F85-9F5C-2B02A913E0D4 Q37466393-851F04CE-5A34-4639-9C55-B8787342AC27 Q38336012-596A787A-4FDA-49B7-BD42-441F72817A63 Q38546908-227A74C1-504D-4C78-A58A-4C7E231D4A73 Q38651628-A1406CBB-2AE4-42B0-B273-40000C796E8E Q38668630-36F93FF3-F02E-44FE-BD91-07586934CB5C Q39084725-D7C8CE26-B4C3-400C-8211-793EA67C8EE2 Q58762112-CB2ED912-E49A-4333-A00A-4F977C652FCA

P2860

Candidate proteins, metabolites and transcripts in the Biomarkers for Spinal Muscular Atrophy (BforSMA) clinical study

http://www.wikidata.org/entity/Q28730283

description

2012 թուականին հրատարակուած գիտական յօդուած

@hyw

2012 թվականին հրատարակված գիտական հոդված

@hy

article publié dans la revue scientifique PLoS ONE

@fr

artículu científicu espublizáu en 2012

@ast

im Januar 2012 veröffentlichter wissenschaftlicher Artikel

@de

scientific article (publication date: 2012)

@en

vedecký článok (publikovaný 2012)

@sk

vědecký článek publikovaný v roce 2012

@cs

wetenschappelijk artikel (gepubliceerd in 2012)

@nl

наукова стаття, опублікована у 2012

@uk

name

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@ast

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@en

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@nl

type

label

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@ast

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@en

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@nl

prefLabel

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@ast

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@en

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@nl

P1433

Q28730283-A56E6021-52DC-4648-8FDD-441DCE9A77B2

P1476

Q28730283-73331F56-31B3-43DD-B044-454C55FF9C2C

P2093

Q28730283-0574C93F-E510-41EE-BEF6-6A0692EBC1CA

Q28730283-1716A175-005F-4512-9591-27B7BCCB7675

Q28730283-1A27D615-3487-43CB-BFAA-D597936A179B

Q28730283-2523DB23-8D25-4759-9B90-B08C44A7742F

Q28730283-29503588-28B4-43DB-A48D-A58F33DE2237

Q28730283-50000DAD-0696-4E7B-AA2F-93F7A5209AC5

Q28730283-B260F7C0-54E5-4BBD-97D9-2B30177087F3

Q28730283-BEC0E1EA-7881-4746-9869-5BEFF88AE1A5

Q28730283-C502416B-6469-4062-907F-355673354702

Q28730283-C76465DE-7955-4165-B61D-291E7861C0AB

P2860

Q28730283-09D4A63D-3B25-48C4-8DA9-4826C067398B

Q28730283-12DBCBB3-FA43-4921-8B2F-9E7CF6E295C7

Q28730283-1578001E-BAC4-47CE-95FB-BC1015939B3B

Q28730283-1A370C44-D48F-490E-BEEF-21CA9C769F8C

Q28730283-25F96380-6975-4405-974C-9CBAA01FF256

Q28730283-2DA5EB04-123E-4409-A034-6324D891699C

Q28730283-2F6D2813-8A6B-41E6-845F-546517CEE628

Q28730283-35D796F5-BE98-478A-BE3C-CB9AFF3E13A1

Q28730283-3787EA64-5A91-4F00-90B7-059D420E3D5B

Q28730283-3C5EC4CE-74E6-41D7-B03C-7CE37C3F070A

P304

Q28730283-1674E42F-B593-456C-AE4A-3F22C696B333

P31

Q28730283-DC2D7CB9-0E23-4138-8AF2-CB07EDB27248

P356

Q28730283-43AAB80A-2982-41EA-AEF9-9F2D50368BF0

P407

Q28730283-D37F3BC4-6BE8-4AAA-97EB-F3AA680A32A4

P433

Q28730283-6646CFE8-E81D-417D-837B-CF354685A59E

P478

Q28730283-7C46491E-840F-4B31-91EF-DF2A64B5BC07

P50

Q28730283-3F5248DC-8F3B-4C8E-91E1-DF681F459ABF

P577

Q28730283-6E8CFFA2-389D-4FDD-990A-A239C3BD0116

P5875

Q28730283-7CB903AA-F817-42D7-AADA-65C03E3C41E2

P698

Q28730283-43B86798-7C4C-426C-951C-A1EEB8D81271

P921

Q28730283-03DC64A4-529C-4372-BB38-72048F856D34

Q28730283-C583D603-E57A-4270-A265-EA13DAB2FC94

P932

Q28730283-54CE856C-C23B-43DC-96D1-FB6725426B1B

P356

JOURNAL.PONE.0035462

P1433

P1476

Candidate proteins, metabolite ...... rophy (BforSMA) clinical study

@en

P2093

Cynthia L Joyce

http://www.w3.org/2001/XMLSchema#string

Dione T Kobayashi

http://www.w3.org/2001/XMLSchema#string

Felicia Trachtenberg

http://www.w3.org/2001/XMLSchema#string

Karen S Chen

http://www.w3.org/2001/XMLSchema#string

Peter Juhasz

http://www.w3.org/2001/XMLSchema#string

Petra Kaufmann

http://www.w3.org/2001/XMLSchema#string

Rebecca H Li

http://www.w3.org/2001/XMLSchema#string

Richard S Finkel

http://www.w3.org/2001/XMLSchema#string

Suzanne J Forrest

http://www.w3.org/2001/XMLSchema#string

Thomas O Crawford

http://www.w3.org/2001/XMLSchema#string

P2860

A novel function for SMN, the spinal muscular atrophy disease gene product, in pre-mRNA splicing

The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy

The SMN-SIP1 complex has an essential role in spliceosomal snRNP biogenesis

Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer.

Summaries of Affymetrix GeneChip probe level data

Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy

The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation

A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy

P304

e35462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0035462

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Kathryn J Swoboda

P577

2012-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224899381

http://www.w3.org/2001/XMLSchema#string

P698

22558154

http://www.w3.org/2001/XMLSchema#string

P921

spinal muscular atrophy

P932

3338723

http://www.w3.org/2001/XMLSchema#string